EP3672975
CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
22.8.2018:
12.4.2023:
18765254.0
:
21.8.2038
:
CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES
22.8.2018
12.4.2023
:
Guangzhou Lupeng Pharmaceutical Company Ltd.:
Room 322, Building B Shilian Science Park No. 33 Science Avenue Huangpu District, Guangzhou City, GuangDong Province, CN
:
CHEN, Yi:
Pleasanton, CA 94566, US
:
LOU, Yan:
Pleasanton, CA 94566, US
:
201762549081 P:
23.8.2017:
US
:
201862615007 P:
9.1.2018:
US
:
US2018047411:
22.8.2018
:
C07D 498/14, C07D 513/14, A61P 35/00, A61P 37/00, A61K 31/553, A61K 31/554